Topics

Science
Ebola patient who died had received ZMapp late in his treatment
Ebola patient who died had received ZMapp late in his treatment

A frantic, 36-hour effort to save the life of Dr. Martin Salia at the Nebraska Medical Center included a rare dose of the experimental Ebola drug ZMapp, hospital officials disclosed Monday. The 44-year-old surgeon contracted the virus while treating patients in Sierra Leone and arrived in Omaha on Saturday in "extremely critical condition," doctors there said. Salia succumbed to the disease at 4 a.m. Monday. ZMapp was one of two unproven medical treatments healthcare workers employed during a round-the-clock struggle to save him, officials said. The second was a transfusion of blood plasma from an unnamed Ebola survivor. Both treatments failed to reverse the course of...

Loading